Clinic of Bashkortostan State Medical University

Ufa 450081

0 studies enrolling now · 2 studies all time

What they study most

UC (Urothelial Cancer)

Studies at this site

• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma — Completed